Juvenescence

Dublin, Ireland · Founded 2016 · Privately Held (backing)

Developer of an anti-aging therapeutics designed to extend healthy lifespan by targeting core aging mechanisms. Juvenescence is based in Dublin, Ireland and was founded in 2016. Its last reported valuation was $502 million in Aug 2019. It has raised $341 million across 4 recorded rounds; the latest was a $9.4 million early-stage round in Dec 2020.

Last reported valuation
$502.0M
Oct 2026
Priced at
—
Total raised
$340.7M
Last round
Early Stage VC
Dec 2020
What is Juvenescence worth?
$502.0Mlast reported valuation · Oct 2026

Juvenescence's last reported valuation, Aug 2019. Nothing priced has surfaced since.

Free account
More of Juvenescence with a free account
  • ·The complete investor list: 18 names
  • ·Watch Juvenescence: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Juvenescence funding history

4 rounds
DateRoundRaisedPost-money
Dec 2020Early Stage VC$9.4M▮
Apr 2019Later Stage VC$56.9M▮
Jun 2018Later Stage VC$53.1M▮
Dec 2017Seed Round$2.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Juvenescence valuation

Juvenescence's last reported valuation was $502 million in Aug 2019. No priced round, secondary trade or fund mark has surfaced since.

How much has Juvenescence raised?

Juvenescence has raised $341 million in total; 4 of its rounds are on record, from 2017 on. The largest on record was a $9.4 million early-stage round in Dec 2020.

Juvenescence has filed 6 Form Ds with the SEC since 2017, most recently in Jun 2021 ($9.4 million sold to 15 investors).

How Juvenescence's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Juvenescence, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Juvenescence

What is Juvenescence worth?
Juvenescence is valued at $502.0M as of Oct 2026. Juvenescence's last reported valuation, Aug 2019. Nothing priced has surfaced since.
How much has Juvenescence raised?
Juvenescence has raised $340.7M in total funding across 4 recorded rounds.
When did Juvenescence last raise?
Juvenescence last raised in Dec 2020 (Early Stage VC), raising $9.4M.